Yunyeong Kim
Breast Cancer Center Cancer Survivor Clinic Surgery Yunyeong Kim Favorite Doctor
  • SpecialtyBenign breast tumor and breast Cancer, other breast diseases
  • Site
Appointment
Schedule / Breast Cancer Center
의료진 진료일정
Week M T W T F S
AM   Present   Absent    
PM   Present   Absent    
Schedule / Cancer Survivor Clinic
의료진 진료일정
Week M T W T F S
AM            
PM            
Schedule / Surgery
의료진 진료일정
Week M T W T F S
AM            
PM            
Clinical Interests

Breast cancer
Benign breast diseases
Other breast diseases and other surgical diseases

Education
Education
Ewha Girl's Foreign Language High School
Gachon University College of Medicine, MD
Gachon University Graduate College of Medicine, M.S
Gachon University Graduate College of Medicine, Ph.D.
Career
Career
Gachon University Gil Medical Center, Intern
Department of Sugery, Gachon University Gil Medical Center, Resident
Breast Cancer Center, Seoul National University Hospital, Clinical Instructor
Breast Cancer Center, Gachon University Gil Medical Center, Clinical Instructor
Breast Cancer Center, Gachon University Gil Medical Center, Clinical Assistant Professor
Breast Cancer Center, Gachon University Gil Medical Center, Assistant Professor
More
Community
Community
More
Training
Training
License
License
Medical License
Sugery Specialist
Yunyeong Kim
Paper
Paper
2018 Gene expression assay and Watson for oncology for optimization of treatment in ER-positive, HER2-negative breast cancer. Plos One. 2018 Jun
2016 Prognostically distinctive subgroup in pathologic N3 breast cancer. J Breast Cancer. 2016 Jun
2015 Predictive significance of P53, Ki-67, and Bcl-2 expression for pathologic complete reponse after neoadjuvant chemotherapy for triple negative breast cancer. J Breast Cancer. 2015 Mar
2015 Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol. 2015 Mar
2015 Changing patterns of microcalcification on screening mammography for prediction of breast cancer. Breast Cancer. 2015 Feb
2015 Nomogram for predicting breast conservation after neoadjuvant chemotherapy. Cancer Res Treat. 2015 Apr
2014 Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery? Springerplus. 2014 Aug
2014 Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer. 2014 Mar
2013 Prognostic effect of preoperative serrum estradiol level in postmenopausal breast cancer. BMC Cancer. 2013 Oct
2013 Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor. Clin Breast Cancer. 2013 Oct
2011 Pattern of lateral neck metastasis and predictors of level V metastasis in papillary thyroid carcinoma. Korean J Endocr Surg. 2011 Sep
More